SB 163 by Sen. Jack Scott (D-Pasadena) was amended to require pharmaceutical companies that sell, deliver, offer for sale or give away medications to publicly disclose:
- All initiated and ongoing clinical trials related to the drug;
- Results of every completed trial; and
- Explanation for any uncompleted trials that the company conducts or sponsors.
AB 2373 by Assembly member Greg Aghazarian (R-Stockton) was approved 9-0 by the Senate Health Committee and rereferred to the Senate Banking, Finance and Insurance Committee (Bill status, 6/14). The bill was amended to limit access to prescription drugs at skilled nursing, nursing and intermediate care facilities that use automated drug delivery systems that are ordered by a prescriber and reviewed by a pharmacist. The measure would expand regulations for automated drug delivery systems that use removable pockets, cards, drawers or similar technology, as well as blister pack cards. Automated drug delivery systems are used to store and distribute drugs to accurately track the movement of drugs into and out of the health care delivery system (Bill text, 6/12). This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.